Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Share:
Related TRIB
25 Stocks Which Rallied Four Days, Then Sold Off On Friday
Benzinga's Top Downgrades
Related VIVO
10 Notable Stocks Trading Ex-Dividend Thursday, November 17
15 Biggest Mid-Day Losers For Wednesday

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.11%. TRIB's revenue for the same period is $79.32 million.

The trailing-twelve-month profit margin at Meridian Bioscience Inc (NASDAQ: VIVO) is 17.59%. VIVO's PEG ratio is 1.27.

The trailing-twelve-month profit margin at Neogen Corp (NASDAQ: NEOG) is 12.53%. NEOG's operating margin for the same period is 18.75%.

The trailing-twelve-month profit margin at Abaxis Inc (NASDAQ: ABAX) is 8.36%. ABAX's ROE for the same period is 7.97%.

Posted-In: Diagnostic Substances Industry Highest Profit Margin small-capTrading Ideas

 

Related Articles (ABAX + NEOG)

View Comments and Join the Discussion!